This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
An index represents a basket of securities designed to mirror a market segment, helping investors gauge overall movement.
14,581 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Explore how Solo Brands (SBDS) 2025 could unfold, with a clear view of revenue drivers, margins, and strategic bets. ...
When a high-profile project runs $114 million over budget, it’s not just news for state treasuries. It’s a real-life ...
Turning 65 triggers Medicare decisions that can impact your budget for decades. This guide explains what every high-i...
The Fed has stopped cutting rates, but that doesn’t mean investors should abandon Realty Income. This article explain...
A major regulatory milestone changes how crypto assets are viewed in the U.S. This guide breaks down the new classifi...
A high-profile legal clash over concert logistics shines a light on how money moves in the music business. This artic...
Nokia climbs on 5G demand and North American telecom spend, while broader markets drift. A practical look at what thi...
Micron Technology stunned investors with a massive quarterly upside. This article breaks down why micron technology's...
Investors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
A prominent market strategist says investors should their money in gold, proposing a 10% allocation to hedge inflatio...
A leading AI company hints at a monumental goal: $9 trillion in market value. We explore what that could mean for inv...